EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pancreatic δ cells are resistant to auto- and paracrine inhibition in human type-2 diabetes

Muhmmad Omar-Hmeadi iD, Lina Matuseviciene iD, Liangwen Liu, Per-Eric Lund iD, Sebastian Barg iD

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2601168123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Muhmmad Omar-Hmeadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Cell Biology, Uppsala University, Uppsala 75123, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Somatostatin-Secreting Cells, Paracrine Communication, Autocrine Communication. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Research Council, Diabetes Wellness Network Sweden, Swedish Diabetes Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Somatostatin secretion from pancreatic δ cells inhibits nearby α- and β cells and tunes the body’s glycemic set-point. The role of δ cells in diabetes remains unclear, in part due to the difficulty separating intrinsic regulation from intraislet paracrine effects. Here, we compared the function of isolated δ cells of cadaveric nondiabetic and type-2 diabetic donors by single cell total internal reflection microscopy, electrophysiology, and secretion measurements. Elevated glucose stimulated exocytosis of somatostatin, which was further amplified by glucagon, exendin-4, or forskolin, independent of diabetic status. gamma-aminobutyric acid (GABA) enhanced exocytosis and electrical activity, while insulin had no detectable effect. Adrenaline and somatostatin strongly inhibited δ cell activity, leading to autocrine feedback inhibition of somatostatin exocytosis. In type-2 diabetes, δ cell inhibition by somatostatin and adrenaline was impaired, together with a marked reduction in somatostatin receptor (SSTR2) surface expression. The data suggest that selective loss of inhibitory control of δ cells may dysregulate intraislet somatostatin signaling in type-2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Somatostatin-Secreting CellsParacrine CommunicationAutocrine CommunicationHumansSomatostatinGlucagonReceptors, SomatostatinExocytosisEpinephrineGlucoseInsulingamma-Aminobutyric AcidColforsinExenatideFemaleMaleInsulin-Secreting Cells

Stichwörter der Autor:innen

exocytosishormone secretionpancreatic isletssomatostatintype-2 diabetes

Substanzen

SomatostatinGlucagonReceptors, SomatostatinEpinephrineGlucoseInsulingamma-Aminobutyric AcidSSTR2 protein, humanColforsinExenatide

Autor:innen und Institutionen

  • Department of Medical Cell Biology, Uppsala University, Uppsala 75123, Sweden.
  • Department of Animal Biosciences, Swedish University of Agricultural Sciences, Uppsala 75007, Sweden.

ORCID-Profile: Muhmmad Omar-Hmeadi, Lina Matuseviciene, Per-Eric Lund, Sebastian Barg

Förderung

  • Swedish Research Council
  • Diabetes Wellness Network Sweden
  • Swedish Diabetes Society
  • Barndiabetesfonden
  • European Foundation for the Study of Diabetes (EFSD)
  • NovoNordisk Foundation
  • Excellence of Diabetes Research in Sweden (EXODIAB)
  • Family Ernfors Foundation

Zitieren

APA

Omar-Hmeadi, M., Matuseviciene, L., Liu, L., Lund, P. E., & Barg, S. (2026). Pancreatic δ cells are resistant to auto- and paracrine inhibition in human type-2 diabetes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2601168123

Vancouver

Omar-Hmeadi M, Matuseviciene L, Liu L, Lund PE, Barg S. Pancreatic δ cells are resistant to auto- and paracrine inhibition in human type-2 diabetes. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2601168123

BibTeX
@article{OmarHmeadi2026,
  author = {Omar-Hmeadi, Muhmmad and Matuseviciene, Lina and Liu, Liangwen and Lund, Per-Eric and Barg, Sebastian},
  title = {Pancreatic δ cells are resistant to auto- and paracrine inhibition in human type-2 diabetes},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2601168123}
}
Kostenlos starten →